OUTCOMES, PROGNOSTIC FACTORS, PREDICTORS FOR TRANSFORMATION TO HIGH-GRADE B-CELL LYMPHOMA, AND THERAPEUTIC MANAGEMENT IN FOLLICULAR LYMPHOMA: REAL-WORLD EVIDENCE FROM A LARGE AND LONG-TERM LATIN-AMERICAN COHORT DS Nogueira; LAPC Lage; CO Reichert; HF Culler; FA Freitas; CR Ferreira; RO Costa; V Rocha; D Levy; J Pereira;

CIRCULATING CELL-FREE DNA (CCFDNA) CONCENTRATIONS MEASURED BY CAPILLARY ELECTROPHORESIS: HIGH COST-EFFECTIVENESS IN DISCRIMINATING DLBCL PATIENTS AND ASSOCIATIONS WITH HIGH TUMOR BURDEN LAPC Lage; HF Culler; CO Reichert; KS Oliveira; GG Lima; FA Freitas; RO Costa; D Levy; V Rocha; J Pereira;

OUTCOMES AND TOXICITY PROFILE IN ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS (DLBCL): A REAL-WORLD AND COMPARATIVE STUDY INVOLVING THREE DIFFERENT DOSE-MODULATED ANTHRACYCLINE-BASED IMMUNOCHEMOTHERAPY REGIMENS IN LATAM LAPC Lage; RN Vita; CO Reichert; HF Culler; FA Freitas; LBO Alves; V Rocha; SAC Siqueira; RO Costa; J Pereira;